|
REXO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.28679999778348E-09 |
| Normal-vs-Stage3 |
6.48409999999267E-05 |
| Normal-vs-Stage4 |
1.27720000131504E-08 |
| Stage1-vs-Stage2 |
6.156600E-01 |
| Stage1-vs-Stage3 |
3.648200E-01 |
| Stage1-vs-Stage4 |
6.037400E-01 |
| Stage2-vs-Stage3 |
7.787400E-01 |
| Stage2-vs-Stage4 |
3.365800E-01 |
| Stage3-vs-Stage4 |
3.868800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
5.56839999665826E-08 |
| Normal-vs-Asian |
4.875800E-01 |
| Caucasian-vs-AfricanAmerican |
9.123900E-02 |
| Caucasian-vs-Asian |
3.215800E-01 |
| AfricanAmerican-vs-Asian |
3.525600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
9.538099999995E-05 |
| Male-vs-Female |
2.44929999999588E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.13110000050143E-07 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
6.49600373492376E-11 |
| Normal-vs-Extreme_Obese |
4.158900E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.476100E-02 |
| Normal_Weight-vs-Obese |
5.326000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.630600E-01 |
| Extreme_Weight-vs-Obese |
1.576350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.706600E-01 |
| Obese-vs-Extreme_Obese |
5.419000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.238800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.4432899320127E-15 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.843200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.027770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.753700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.522400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.035000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.285600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.110800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
8.72929506456899E-11 |
| Normal-VS-KIRP CIMP |
8.828000E-01 |
| Normal-VS-Unclassified PRCC |
1.39310000202286E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.389590E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.782200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.862600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.744780E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.828200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.321010E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.71249969339283E-10 |
| Normal-vs-N1 |
3.00019999999179E-06 |
| Normal-vs-N2 |
1.5392000000114E-06 |
| N0-vs-N1 |
9.060600E-01 |
| N0-vs-N2 |
5.544000E-01 |
| N1-vs-N2 |
4.857600E-01 |
|
|
